Výběr Zpět, zpět, zpět část Horlivost bladder cancer cd317 metastatic marker potlesk pyramida Melodický
Exosomes as a new frontier of cancer liquid biopsy | Molecular Cancer | Full Text
Bladder Cancer Markers (Bladder tumor antigen or BTA), NMP22 - YouTube
Frontiers | Targeted Therapy With Immunoconjugates for Multiple Myeloma
Statistical analysis of correlations among serine... | Download Scientific Diagram
BST-2 promotes survival in circulation and pulmonary metastatic seeding of breast cancer cells | Scientific Reports
Frontiers | The Potential Biomarkers and Immunological Effects of Tumor-Derived Exosomes in Lung Cancer
Future directions and management of liquid biopsy in non-small cell lung cancer
Loss of the Urothelial Differentiation Marker FOXA1 Is Associated with High Grade, Late Stage Bladder Cancer and Increased Tumor Proliferation | PLOS ONE
Metastasis Markers in Bladder Cancer: A Review of the Literature and Clinical Considerations - ScienceDirect
In vivo expression profile of the antiviral restriction factor and tumor-targeting antigen CD317/BST-2/HM1.24/tetherin in humans | PNAS
Frontiers | Increased Expression of SHMT2 Is Associated With Poor Prognosis and Advanced Pathological Grade in Oral Squamous Cell Carcinoma
Novel therapies in urothelial carcinoma: a biomarker-driven approach - Annals of Oncology
Overexpression of the transmembrane protein BST-2 induces Akt and Erk phosphorylation in bladder cancer
The role of exosomes in lung cancer metastasis and clinical applications: an updated review | Journal of Translational Medicine | Full Text
US20210155602A1 - Tetrahydroquinolino derivatives for the treatment of metastatic and chemoresistant cancers - Google Patents
MiR-302b Suppresses Tumor Metastasis by Targeting Frizzled 6 in OSCC - S. Sun, J. Wang, J. Liu, F. Yin, C. Xin, X. Zeng, J. Li, Q. Chen, 2021
Expanding cross-presenting dendritic cells enhances oncolytic virotherapy and is critical for long-term anti-tumor immunity | Nature Communications
The Immunomodulation Potential of Exosomes in Tumor Microenvironment
Impact of immunohistochemistry-based subtyping of GATA3, CK20, CK5/6, and CK14 expression on survival after radical cystectomy for muscle-invasive bladder cancer | Scientific Reports
Overexpression of the transmembrane protein BST-2 induces Akt and Erk phosphorylation in bladder cancer
Distinguishing primary adenocarcinoma of the urinary bladder from secondary involvement by colorectal adenocarcinoma: extended immunohistochemical profiles emphasizing novel markers | Modern Pathology
Metastasis Markers in Bladder Cancer: A Review of the Literature and Clinical Considerations - ScienceDirect
BST-2: at the crossroads of viral pathogenesis and oncogenesis | Future Virology
CD317 Signature in Head and Neck Cancer Indicates Poor Prognosis - L.-L. Yang, L. Wu, G.-T. Yu, W.-F. Zhang, B. Liu, Z.-J. Sun, 2018
In vivo expression profile of the antiviral restriction factor and tumor-targeting antigen CD317/BST-2/HM1.24/tetherin in humans | PNAS